 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > ISTA Pharmaceuticals, Inc.
 |
ISTA Pharmaceuticals, Inc. |
 |
 |
 |
PROFILE |
 |
ISTA Pharmaceuticals has its sights on developing pharmaceutical treatments for eye diseases. The firm develops ophthalmic drugs based on hyaluronidase, a group of naturally occurring enzymes. Its lead drug candidate, Vitrase, may treat vitreous hemorrhaging, a condition in which blood leaks into the fluid between the lens and the retina and obscures vision, as well as diabetic retinopathy, in which abnormal blood vessels in the back of the eye impair vision. Other products in development include Keratase and Keraform, treatments for corneal diseases. ISTA Pharmaceuticals has a worldwide (excluding Mexico and Japan) marketing and sales agreement with Allergan for Vitrase; Allergan owns about 7% of the firm.
COMPETITION |
 |
Alcon Laboratories, Inc. (dossier)
Allergan Specialty Therapeutics, Inc. (ASTI)
Bausch & Lomb Incorporated (BOL)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 0.10
1-Yr. Sales Growth: 0.0%
Employees: 39
Revenue per employee: $2,564.10
KEY PEOPLE |
 |
Edward H. Danse
CEO
J. C. MacRae
CFO
CONTACT INFO |
 |
15279 Alton Pkwy.
Irvine, CA 92618
US
Phone: 949-788-6000
Fax: 949-788-6010
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |